VEGFA and triple-negative breast carcinoma: Although we did not conduct a standalone study to assess the individual contributions of the EGFR, cMET, and VEGFA arms in one NSCLC xenograft model using inert arm comparator molecules, we performed such study in a triple-negative breast cancer (TNBC) model.